FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Verburg

Research Profile

Chemicals & Drugs

Procedures

Double-Blind Method

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
MIchael Snabes; Artur J Jakimiuk; Jan Kotarski; Teresa K Katz; Mark T Brown; Kenneth M Verburg
Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy.
William B White; Christine West; Jeffrey S Borer; Philip B Gorelick; Lisa M LaVange; Sharon X Pan; Ethan Weiner; Kenneth M Verburg
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
Andrew Whelton; J L Lefkowith; Christine West; Kenneth M Verburg
Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Verburg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: MIchael Snabes; Artur J Jakimiuk; Jan Kotarski; Teresa K Katz; Mark T Brown; Kenneth M Verburg
Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy.
Journal of clinical anesthesia 2007;19(6):448-55.
2007: William B White; Christine West; Jeffrey S Borer; Philip B Gorelick; Lisa M LaVange; Sharon X Pan; Ethan Weiner; Kenneth M Verburg
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
The American journal of cardiology 2007;99(1):91-8.
2006: Andrew Whelton; J L Lefkowith; Christine West; Kenneth M Verburg
Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen.
Kidney international 2006;70(8):1495-502.
2006: Richard Pollak; Gary A Raymond; Richard M Jay; Howard J Hillstrom; Kieran T Mahan; Dennis S Riff; Ellis L Jacobs; Mark T Brown; Kenneth M Verburg
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy.
Journal of the American Podiatric Medical Association 2006;96(5):393-407.
2006: Nancy A Nussmeier; Andrew Whelton; Mark T Brown; Girish P Joshi; Richard M Langford; Neil K Singla; Mark E Boye; Kenneth M Verburg
Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery.
Anesthesiology 2006;104(3):518-26.
2006: Gary W Williams; Alan J Kivitz; Mark T Brown; Kenneth M Verburg
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Clinical therapeutics 2006;28(2):204-21.
2005: Nancy A Nussmeier; Andrew Whelton; Mark T Brown; Richard M Langford; Andreas Hoeft; Joel L Parlow; Steven W Boyce; Kenneth M Verburg
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.
The New England journal of medicine 2005;352(11):1081-91.
2004: Jay L Goldstein; Glenn Eisen; N Agrawal; William F Stenson; Jeffrey D Kent; Kenneth M Verburg
Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Alimentary pharmacology & therapeutics 2004;20(5):527-38.
2004: Michelle Petri; Stephen L Hufman; Gregory Waser; Harry Cui; MIchael Snabes; Kenneth M Verburg
Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis.
The Journal of rheumatology 2004;31(8):1614-20.
2003: Karel Pavelka; David P Recker; Kenneth M Verburg
Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
Rheumatology (Oxford, England) 2003;42(10):1207-15.
2003: Jay L Goldstein; Alan J Kivitz; Kenneth M Verburg; David P Recker; R C Palmer; Jeffrey D Kent
A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects.
Alimentary pharmacology & therapeutics 2003;18(1):125-32.
2003: Lowell W Reynolds; Robert K Hoo; Robert J Brill; Janine North; David P Recker; Kenneth M Verburg
The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty.
Journal of pain and symptom management 2003;25(2):133-41.
2002: Elizabeth Tindall; John T Sharp; Aimee Burr; T Kirsten Katz; Carl B Wallemark; Kenneth M Verburg; James B Lefkowith
A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib.
Clinical therapeutics 2002;24(12):2051-63.
2002: David H Sikes; Naurang M Agrawal; William W Zhao; Jeffrey D Kent; David P Recker; Kenneth M Verburg
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.
European journal of gastroenterology & hepatology 2002;14(10):1101-11.
2002: Paul J Desjardins; Vincent S Shu; David P Recker; Kenneth M Verburg; Clifford J Woolf
A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain.
Anesthesiology 2002;97(3):565-73.
2002: Stephen E Daniels; Sheela Talwalker; Sarah Torri; MIchael Snabes; David P Recker; Kenneth M Verburg
Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.
Obstetrics and gynecology 2002;100(2):350-8.
2002: Stephen E Daniels; Paul J Desjardins; Sheela Talwalker; David P Recker; Kenneth M Verburg
The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery.
Journal of the American Dental Association (1939) 2002;133(5):611-21; quiz 625.
2002: William B White; Jeffrey Kent; Addison Taylor; Kenneth M Verburg; James B Lefkowith; Andrew Whelton
Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.
Hypertension 2002;39(4):929-34.
2002: Tariq Khan; Susan K Paulson; Kenneth M Verburg; James B Lefkowith; Timothy J Maziasz
Pharmacology of cyclooxygenase-2 inhibition in the kidney.
Kidney international 2002;61(4):1210-9.
2002: James Fricke; John Varkalis; Sam Zwillich; Rebecca Adler; Eliot Forester; David P Recker; Kenneth M Verburg
Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery.
American journal of therapeutics 2002;9(2):89-97.
2002: William B White; Gerald Faich; Andrew Whelton; Clement Maurath; Nancy J Ridge; Kenneth M Verburg; G Steven Geis; James B Lefkowith
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.
The American journal of cardiology 2002;89(4):425-30.
2002: Frederic Camu; Tessa Beecher; David P Recker; Kenneth M Verburg
Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty.
American journal of therapeutics 2002;9(1):43-51.
2001: Alan J Kivitz; Roland W Moskowitz; E Woods; Richard C Hubbard; Kenneth M Verburg; James B Lefkowith; G Steven Geis
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
The Journal of international medical research 2001;29(6):467-79.
2001: Jay L Goldstein; P Correa; William W Zhao; Aimee Burr; Richard C Hubbard; Kenneth M Verburg; G Steven Geis
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
The American journal of gastroenterology 2001;96(4):1019-27.
2001: Andrew Whelton; John G Fort; J A Puma; D Normandin; Alfonso E Bello; Kenneth M Verburg
Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.
American journal of therapeutics 2001;8(2):85-95.
2001: J S Gimbel; A Brugger; W Zhao; Kenneth M Verburg; G Steven Geis
Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.
Clinical therapeutics 2001;23(2):228-41.
2001: Kenneth M Verburg; Timothy J Maziasz; E Weiner; L Loose; G Steven Geis; Peter C Isakson
Cox-2-specific inhibitors: definition of a new therapeutic concept.
American journal of therapeutics 2001;8(1):49-64.
2000: F E Silverstein; Gerald Faich; Jay L Goldstein; Lee S Simon; T Pincus; Andrew Whelton; Robert W Makuch; Glenn Eisen; Naurang M Agrawal; William F Stenson; Aimee Burr; William W Zhao; Jeffrey D Kent; James B Lefkowith; Kenneth M Verburg; G Steven Geis
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
JAMA : the journal of the American Medical Association 2000;284(10):1247-55.
2000: Jay L Goldstein; F E Silverstein; Naurang M Agrawal; Richard C Hubbard; J Kaiser; Clement Maurath; Kenneth M Verburg; G Steven Geis
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
The American journal of gastroenterology 2000;95(7):1681-90.
2000: Andrew Whelton; G Schulman; Carl B Wallemark; E J Drower; Peter C Isakson; Kenneth M Verburg; G Steven Geis
Effects of celecoxib and naproxen on renal function in the elderly.
Archives of internal medicine 2000;160(10):1465-70.
2000: Andrew Whelton; Clement Maurath; Kenneth M Verburg; G Steven Geis
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.
American journal of therapeutics 2000;7(3):159-75.
2000: Willis C Maddrey; Clement Maurath; Kenneth M Verburg; G Steven Geis
The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.
American journal of therapeutics 2000;7(3):153-8.
1999: Paul Emery; H Zeidler; T K Kvien; M Guslandi; R Naudin; H Stead; Kenneth M Verburg; Peter C Isakson; Richard C Hubbard; G Steven Geis
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.
Lancet 1999;354(9196):2106-11.
1999: Lee S Simon; A L Weaver; D Y Graham; Alan J Kivitz; P E Lipsky; Richard C Hubbard; Peter C Isakson; Kenneth M Verburg; SS Yu; William W Zhao; G Steven Geis
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1999;282(20):1921-8.
1999: WG Bensen; J J Fiechtner; J I McMillen; William W Zhao; SS Yu; E M Woods; Richard C Hubbard; Peter C Isakson; Kenneth M Verburg; G Steven Geis
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
Mayo Clinic proceedings. Mayo Clinic 1999;74(11):1095-105.